Longevity Health Holdings delays quarterly filing after convertible note valuation review stalls
XAGE•Longevity Health Holdings expects to file its delayed September 30, 2026, quarterly report within a five-calendar-day extension. It expects a net loss of approximately $2.5 million, versus $1.4 million a year earlier, including approximately $1.9 million in noncash charges tied to convertible notes issued in a litigation settlement.
1. Filing delay
Longevity Health Holdings said it expects to file its delayed quarterly report for the period ended September 30, 2026, within the five-calendar-day extension. Late receipt of a third-party valuation of convertible notes delayed the accounting firm's review of complex accounting judgments. A November 12 Microsoft 365 disruption further delayed coordination by interrupting email and document access.
2. Expected loss
The company expects a quarterly net loss of approximately $2.5 million, compared with approximately $1.4 million a year earlier. Approximately $1.9 million in noncash charges tied to convertible notes issued in a litigation settlement primarily drove the larger loss.




